drug

GDC-4198

1 story · latest Oct 9, 2026

Follow GDC-4198. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.

Follow free for 14 daysNo card.

Status: Investigational
Codes: RGT-419B, RO7840734
Trials: 1 registered trial in coverage

Relationships

Developed by Roche

Timeline

Genentech lists Phase Ib KRAS G12D trial; Roche-sponsored DLBCL study shows update

Oct 9Weekly roundup, 9 itemsalectinib cisplatinUpdated

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.